Bloomberg: Rising Insulin Prices Spur Lawmakers to Investigate

Bloomberg: Rising Insulin Prices Spur Lawmakers to Investigate

“When there are competing substitutable insulins, pharmacy benefit managers are reducing insulin costs,” the PCMA said in a June 22 statement provided to Bloomberg BNA. “However, there are different types of insulin that don’t impact patients in the same way. As a result, drug companies have significant power to keep prices high.”